AMD, Absci and AI
AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector. The effort will place particular emphasis on developing technologies that can advance drug discovery.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
HSBC lowered its rating on Advanced Micro Devices stock amid several concerns including the chipmaker's ability to compete ...
Artificial intelligence (AI) has come a long way in recent years. Businesses are starting to see tangible savings from ...
In an internal test, AMD used the Ryzen AI Max+ 395 to run a version of the Llama 70B large language model. The company says ...
Advanced Micro Devices' diversified revenue streams provide a cushion against potential slowdowns in AI hardware CapEx. See ...
It's clear that AMD isn't the AI company Nvidia is. Its $3.5 billion in data center revenue in Q3 was a fraction of Nvidia's ...
We recently published a list of 10 AI Stocks Wall Street is Talking About. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback